Based on the provided search results, Imugene has collaborations with other companies,
Imugene has collaborations with:
Arovella Therapeutics Ltd to test the integration of Arovella’s CAR19-iNKT cell therapy with Imugene’s onCARlytics platform.RenovoRx, Inc.
to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors.
NeoImmuneTech, Inc.
to evaluate the combination potential of NeoImmuneTech’s immune cell amplifier NT-I7 with
Imugene’s azer-cel allogeneic CAR T cells.
These collaborations aim to improve cancer treatments and leverage each company’s expertise and technology.
GLALTH.. Mal
Based on the provided search results, Imugene has collaborations...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $80.20M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $342.6K | 922.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 138148 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 123242 | 2 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |